Serial assay of serum CA 125 was carried out in five patients with advanced primary
carcinoma of the fallopian tube. Pretreatmental levels of these patients were elevated …

Our study reports 6 patients with advanced adenocarcinoma of the fallopian tube, with
elevated levels of serum CA 125 (> 35 U/ml). In two patients the serum CA 125 values were …

Plasma levels of CA 125 were determined in 113 patients with ovarian cancer of epithelial
origin. Of these, 69 patients had CA 125 measured before the first laparotomy and 84.6% of …

The value of CA 125 measurement in the diagnosis and follow–up of ovarian cancer was
studied in 102 patients. The CA 125 levels were elevated in 88%(3221365) of samples from …

Serum levels of CA 125 were determined in 239 patients suffering from gynecological
malignancies. The upper limit for normal was 35 U/ml. Raised levels were found in 82% of …

Pre‐operative serum CA 125 levels were elevated (> 35U/ml) in 44 of 46 (96%) patients with
epithelial ovarian cancer. Their serum CA 125 levels ranged from 36 to 8670 U/ml and a …

Serum CA 125 levels were evaluated in 227 patients with ovarian cancer. CA 125 levels
were elevated in 86% of the patients. All histologic types, including mucinous tumors, were …

Elevated CA 125 level was noted in 0.2-5.9% healthy women, 22-27.8% patients with
benign ovarian cysts, and approximately 80% patients with nonmucinous ovarian cancer. In …

Three hundred and ninety-five CA 125 serum values of 72 patients with ovarian cancer were
correlated with the clinical status. With a threshold value of 35 U/ml we found true negative …

The CA 125 radioimmunoassay has been increasingly used to monitor the course of
patients with ovarian epithelial carcinomas. The purpose of this report is to describe our …